Publications

Department of Medicine faculty members published more than 3,000 peer-reviewed articles in 2022.

Filter by

Guía Exarmed 3a Ed. Insuficiencia Cardiaca (Chapter)

2012

Authors: Sergio A. Torres and Carlos A. Tafich

Guia Exarmed 3a Ed. Cardiopatías Congénitas (Chapter)

2012

Authors: Sergio A. Torres and Daniel Moreira

Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction.

2012

Authors: Torres SA, Cheema O, Shah DJ, Torre-Amione G, Estep JD

Head injury, α-synuclein Rep1, and Parkinson's disease.

2012

Authors: Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM

2.17.3 TRICHLOROETHYLENE (TCE) EXPOSURE AND PARKINSON'S DISEASE (PD) RISK.

2012

Authors: S.M. Goldman

Mycobacterial Infections in the non-HIV–Infected Patient.

2012

Authors: Melissa Nyendak, Tarek Eid, Payam Nahid, Kevin Winthrop, David Lewinsohn

Major Radiation Exposure.

2012

Authors: Denis D. Bensard, Philip F. Stahel, Jorge Cerdá, Babak Sarani, Sajid Shahul, Daniel Talmor, Peter M. Hammer, C. William Schwab, Steven Reynolds, Omar Ahmad, Tsuyoshi Kaneko, Anthony L. Estrera, William A. Knight, Bradley P. Dixon, Richard L. Gamelli, Joseph A. Posluszny, Mansoor N. Bangash, Rupert M. Pearse, Albert J. Ruggieri, Richard J. Levy, Clifford S. Deutschman, Clifford S. Deutschman, Richard J. Levy, Prasanna Simha Mohan Rao, John P. Kress, Sabino Scolletta, Norman E. McSwain, Jeffry L. Kashuk, Angela Sauaia, Ernest E. Moore, Per-Olof J. Hasselgren, Wade R. Smith, John T. Riehl, Denis D. Bensard, Philip F. Stahel, Berton R. Moed, B. Kirke Bieneman, Berton R. Moed, Clay C. Cothren, Ernest E. Moore, Nima Majlesi, Richard D. Shih, Eelco F. M. Wijdicks, Melissa Nyendak, Tarek Eid, Payam Nahid, Kevin Winthrop, David Lewinsohn, Julie P. Chou, Tom Lim, Andrew G. Lee, Christopher H. Mody, Tom Lim, Julie P. Chou, Christopher H. Mody, Nathan T. Mowery, Alexander L. Colonna, J. Wayne Meredith, Alain Combes, Jonathan R. Egan, Marino S. Festa, A. Montcriol, Y. Asencio, F. Kerbaul

Use of the Informed Consent Model in the Provision of
Cross-Sex Hormone Therapy: A Survey of the Practices
of Selected Clinics

2012

Authors: Deutsch MB

Chapter 42. Special Issues Regarding Women with HIV Infection. In Sande’s HIV/AIDS Medicine: Medical Management of AIDS. Volberding P, Greene WC, Lange JMA, Sewankambo NK, Gallant JE (Eds).

Chapter 42. Special Issues Regarding Women with HIV Infection. In Sande’s HIV/AIDS Medicine: Medical Management of AIDS. Volberding P, Greene WC, Lange JMA, Sewankambo NK, Gallant JE (Eds)

2012

Authors: Greenblatt RM and Gandhi M.

Volume 50 of Issue 1 | Medical care

The use and misuse of thrombolytic therapy within the Veterans Health Administration.

2012

Authors: Keyhani S, Arling G, Williams LS, Ross JS, Ordin DL, Myers J, Tyndall G, Vogel B, Bravata DM

View Abstract

BACKGROUND

Within the Veterans Health Administration (VHA), approximately 6000 veterans are hospitalized with acute ischemic stroke annually. We examined the use and misuse of thrombolytic therapy with tissue plasminogen activator (tPA) in a national sample of veterans who were admitted to a VHA Medical Center (VAMC) with acute ischemic stroke.

METHODS

Medical record reviews were conducted on 5000 acute stroke patients who were admitted to a VAMC in 2007. Patients were defined as eligible to receive tPA if they arrived at the hospital within 3 hours of stroke symptom onset and had no contraindications to tPA. We compared eligible patients who received tPA to those who did not and examined the distribution of eligible patients across the 129 VAMCs included in this study.

RESULTS

Among the 3931 ischemic stroke patients, 174 (4.4%) were eligible for tPA. Among the 135 patients who arrived within 2 hours of symptom onset which allowed adequate time for testing and evaluation, 19 (14.1%) received tPA. An additional 11 patients received tPA but did not meet eligibility criteria. Eligible patients receiving tPA were similar to eligible patients not receiving tPA in terms of clinical conditions and time to brain imaging. Among the 30 patients that received tPA, 5 (16.6%) received the wrong dose. Among the 85 VAMCs that received ≥1 eligible patient, on average 2.3 patients were eligible for tPA annually.

CONCLUSIONS

Relatively few eligible veterans receive thrombolysis across the VHA system. Strategies to improve thrombolysis delivery will have to account for the low annual volume of eligible stroke patients cared for at individual VAMCs.

View on PubMed